Healthcare

In an increasingly convergent industry such as healthcare, business collaborations are not only a necessity, but an inevitability. It is interesting to note that technologies and market segments that receive the most funding and research focus, are also the areas that are ripe for collaborative partnerships. Market segments such as personalized med...

This issue profiles cancer cell imaging technologies.

15 Dec 2015  |  Asia Pacific

Analysis of the Medical Imaging Market in Selected ASEAN Countries

Growth and Trends in CT, MR, PET, and SPECT Modalities

Infographics

×

This research service provides an analysis of the medical imaging market in Indonesia, Malaysia, Singapore, and Thailand. It provides a detailed analysis of current trends, market size, revenue forecasts, and drivers and restraints for the computed tomography (CT), medical resonance (MR), Positron emission tomography (PET), and single-photon emissi...

This issue profiles technology advances and trends for the treatment of sleep apnea.

The US healthcare industry is undergoing a major transition toward value-based care, affecting all its stakeholders. Centers for Medicare and Medicaid Services (CMS) are steering this transition by developing policies and alternative payment models that affect all reimbursements for healthcare services. This document provides insight into CMS’s 2...

Shifts to how healthcare is delivered, where it is delivered, and how it is paid for are necessitating adoption of innovative tools for managing information. A key challenge is to appropriately assess the importance of various quantitative metrics, as well as correlate with qualitative recommendations and patient history. The voluminous forms of un...

The increased demand for fibrinogen and the development of innovative delivery systems such as sprays and patches are fuelling the growth of the fibrinogen market. This research service provides a detailed assessment of the global fibrinogen market, covering the current market scenario and growth prospects for the period 2015–2020. Both marketed ...

The Chinese pharmaceutical market is expected to be the third-largest in the world in 2013. This research service analyzes various aspects of the Chinese pharmaceutical market between 2007 and 2016. Rising income, improving healthcare infrastructure, and insurance systems are some factors that drive this market. The study discusses in detail the ma...

This research service presents an overview and analysis of the Australian contract research organization (CRO) market. The research service provides market revenue forecasts by phase and therapeutic type and discusses major issues and challenges, unmet needs, and developing trends in the CRO market. The study covers the complete life cycle of the C...